Skip to main content
Fig. 4. | Clinical Epigenetics

Fig. 4.

From: Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax

Fig. 4.

182KO ALL cells are enriched more LIC (B220+CD43+) cells. A The percentage of LIC was measured in BM GFP+ cells from 182WT and 182KO ALL mice. Representative flow plots (left) and statistical analysis of the percentage of LIC (right) are shown. B Edu staining for BM GFP+ cells from 182WT and 182KO ALL mice. Shown are the representative flow plots (left) and statistical analysis of the percentage of Edu+ cells (right). CE BM GFP+ cells were sorted from 182WT and 182KO ALL mice and plated on murine methylcellulose medium (8000/dish). Colony number (D) was counted after ten days of culture, and total cell number (E) was measured after colonies were washed. The Bar represent 10 μm. F and G OS was counted in primary (n = 7 for WT and KO mice) and secondary BMT (n = 5 for WT and KO mice). H Limiting dilution assay of BM GFP+ cells from secondary BMT leukemic mice with 182WT (n = 7) and 182KO (n = 7). The frequency of LSC and P value were determined via L-calc software. *P < 0.05; **P < 0.01; ***P < 0.001

Back to article page